Archives
-
Sodium Oxamate: LDH-A Workflow for Cancer Studies
2026-09-09
Sodium Oxamate is a water-compatible competitive inhibitor of LDH-A that helps connect lactate production with proliferation, redox balance, DNA repair, and treatment response. This workflow-focused guide shows how to use it as a Warburg effect inhibitor model, interpret lactate-dependent phenotypes, and troubleshoot concentration, timing, and assay-specific problems.
-
DiscoveryProbe Stem Cell Compound Library Plus
2026-09-08
DiscoveryProbe Stem Cell Compound Library Plus connects pathway-focused chemistry with quantitative phenotypic readouts across self-renewal, differentiation, proliferation, and disease-model assays. Its 280-compound design also supports high-content parasite stem-cell screening, where imaging-based neoblast measurements can reveal sublethal effects missed by morphology or motility alone.
-
EZ Cap™ Cy5 EGFP mRNA: Assay Design
2026-09-08
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables a two-channel mRNA delivery and translation efficiency assay. This guide explains how to separate cellular uptake, intracellular release, and EGFP expression using Cy5 tracking and Cap1-engineered reporter biology.
-
MG-132 (Z-LLL-al) Workflows for Cell Assays
2026-09-07
MG-132 (Z-LLL-al) offers a fast, cell-permeable route to perturb proteasome function in apoptosis assay, cell-cycle, mitochondrial, and oxidative-stress workflows. This practical guide connects concentration control, orthogonal readouts, and recent antigen-design logic to improve experimental interpretation without confusing a chemical stress model with antiviral efficacy.
-
tRF16–ALKBH5 Axis in Osteoarthritis
2026-09-07
This study identifies tRF16 as an overexpressed regulatory RNA that worsens osteoarthritis by suppressing the m6A demethylase ALKBH5, destabilizing NFKBIA mRNA, and activating NF-κB signaling. Its combined human-tissue, rat-model, and IL-1β-induced chondrocyte evidence positions the tRF16–ALKBH5–NFKBIA pathway as a mechanistic and potentially diagnostic framework for osteoarthritis research.
-
Isradipine (Dynacirc) in Calcium Channel Assays
2026-09-05
Isradipine (Dynacirc) provides a practical L-type calcium-channel perturbation strategy for vascular smooth muscle, neuronal calcium-imaging, and hypertension research. This guide pairs compound-handling guidance with a toxin-based comparator framework to help researchers separate L-type effects from broader neuronal calcium-channel pharmacology.
-
ML216: BLM Inhibition Meets Synthetic Lethality
2026-09-04
ML216 is a BLM helicase inhibitor for dissecting DNA repair, homologous recombination, and cancer-cell vulnerabilities. This guide connects biochemical selectivity with assay design and explains how WRN-focused MSI research should—and should not—be interpreted using ML216.
-
Halo-seq Maps Subcellular RNA Transcriptomes
2026-09-04
The Halo-seq study introduced a light-activated RNA proximity-labeling strategy that combines radical generation with click chemistry to quantify spatially defined transcriptomes. Its application to nuclear, nucleolar, and cytoplasmic RNA revealed AU-rich element enrichment in nuclear transcripts and identified transcripts whose export depends on HuR.
-
Arachidonic Acid: Mechanism, Evidence & Workflows
2026-09-03
Arachidonic Acid is a polyunsaturated omega-6 fatty acid that links membrane phospholipid remodeling with eicosanoid biosynthesis and lipid signaling. Recent mouse and human rabies-vaccine data support dietary arachidonic acid as an investigational modulator of humoral immunity, while laboratory use requires solvent, concentration, oxidation, and storage controls.
-
Lnc21q22.11 Suppresses Gastric Cancer via MEK/ERK
2026-09-03
The 2025 Epigenetics study identifies Lnc21q22.11 as a 1,202-nucleotide tumor-suppressive lncRNA whose reduced expression is linked to histone methylation and gastric cancer progression. Functional and xenograft experiments connect this transcript to MYH9-dependent inhibition of MEK/ERK signaling, providing a mechanistic framework for biomarker and therapeutic research.
-
RB1 Loss and the Earliest Cell of Retinoblastoma
2026-09-02
A 2026 Cell Death and Disease study uses RB1-deficient human retinal organoids and longitudinal single-cell analysis to identify ATOH7+/RXRγ+ nascent cone precursors as the earliest cellular origin of human retinoblastoma. The work separates the effects of complete and monoallelic RB1 loss, providing a developmental framework for studying tumor initiation and prioritizing therapeutic targets.
-
Clathrin-Mediated Entry of Type III GCRV
2026-09-02
Wang et al. used pharmacological inhibition, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated, pH-dependent pathway. The study also shows that Nocodazole did not block infection under the tested conditions, making the compound useful as a negative mechanistic probe rather than evidence that microtubules are universally irrelevant to reovirus biology.
-
PCMT1 and Ovarian Cancer Metastasis: CRISPR Evidence
2026-09-01
Zhang et al. used a genome-wide CRISPR/Cas9 knockout screen to identify PCMT1 as a driver of anoikis resistance and ovarian cancer metastatic behavior. The study connects extracellular PCMT1 to LAMB3-dependent integrin–FAK–Src signaling, highlighting a potentially targetable interface between tumor cells and the extracellular matrix.
-
1-myristoylglycerophosphocholine in Fibrosis Assays
2026-09-01
Use 1-myristoylglycerophosphocholine, also known as 14:0 Lyso-PC, as a defined lysophospholipid perturbation for fibroblast activation, epithelial lipid-transfer, and receptor-mediated signaling assays. This guide translates the HMGCS2–LysoPC pulmonary fibrosis findings into practical dosing, controls, preparation steps, and troubleshooting strategies.
-
2-Deoxy-D-glucose Workflows for Metabolic Stress
2026-08-31
2-Deoxy-D-glucose enables controlled glycolysis inhibition across cancer, viral replication, and cellular energy-stress models. This practical guide connects dose selection and orthogonal readouts with new assay ideas inspired by lactate-regulated, insulin-independent glucose uptake.